A Study of Radiotherapy With or Without Concurrent Cisplatin in Patients with Nasopharyngeal Cancer

Association of Patient Demographic Characteristics and Insurance Status with Survival in Cancer Randomized Clinical Trials with Positive Findings

JM Unger;CD Blanke;M Leblanc;W Barlow;R Vaidya;M Fleury;SD Ramsey;DL Hershman JAMA Network Open Apr 1;3(4):e203842

PMid: PMID32352530 | PMC number: PMC7193331

The effect of positive SWOG treatment trials on survival of patients with cancer in the US population

JM Unger;M Leblanc;CD Blanke JAMA Oncology Oct 1;3(10):1345-1351

PMid: PMID28586789; PMC5710507

The impact of positive SWOG treatment trials on population survival

J Unger;M LeBlanc;C Blanke J Clin Oncol 35, 2017 (suppl; abstr 6513); American Society of Clinical Oncology Annual Meeting (June 2-6, 2017, Chicago, IL), poster discussion

Surrogate endpoints for overall survival in loco-regionally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis

F Rotolo;J Pignon;J Bourhis;S Marguet;J Leclercq;WT Ng;J Ma;ATC Chan;P-Y Huang;G Zhu;DTT Chua;Y Chen;H-Q Mai;DLW Kwong;YL Soong;J Moon;Y Tung;K-H Chi;G Fountzilas;L Zhang;E Hui;AWM Lee;P Blanchard;S Michiels Journal of the National Cancer Institute, Apr;109(4). pii: djw239.

PMid: PMID27927756 | PMC number: PMC6059121

What is the best treatment for locally advanced nasopharyngeal carcinoma? An individual patient data network meta-analysis

L Ribassin-Majed;S Marguet;AWM Lee;WT Ng;J Ma;ACT Chan;P-Y Huang;G Zhu;T Chua;Q Chen;H-Q Mai;DL Kwong;C Shie-Lee;J Moon;Y Tung;K-H Chi;G Fountzilas;J Bourhis;J-P Pignon;P Blanchard Journal of Clinical Oncology, Feb 35(5):499-505

PMid: PMID27918720 | PMC number: PMC5791836

Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis

P Blanchard;A Lee;S Marguet;J Leclercq;WT Ng;J Ma;A Chan;P-Y Huang;E Benhamou;G Zhu;D Chua;Y Chen;H-Q Mai;D Kwong;SL Cheah;J Moon;Y Tung;K-H Chi;G Fountzilas;L Zhang;M Hareyama;EP Hui;T-X Lu;J Bourhis;J-P Pignon Lancet Oncology Jun;16(6):645-655

PMid: PMID25957714 | PMC number: n/a

Meta-analysis of chemotherapy in nasopharyngeal carcinoma (MAC-NPC): An update on 4,798 patients

P Blanchard;AMW Lee;J Leclercq;S Marquet;WT Ng;J Ma;ATC Chan;P Huang;G Zhu;DTT Chua;HQ Mai;J Wee;DLW Kwong;J Moon;KH Chi;G Fountzilas;M Hareyama;L Zhang;J Bourhis;J-P Pignon Journal of Clinical Oncology 32:5s (suppl; abstr 6022); ASCO (May 30-June 3, 2014, Chicago, IL), poster highlights session;

The Southwest Oncology Group: progress in cancer research [PMID18929152]

CA Coltman Seminars in Oncology 35(5):545-552

Superiority of five year survival with chemo-radiotherapy (CT-RT) vs radiotherapy in patients with locally advanced nasopharyngeal cancer (NPC). Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) Phase III study: final report

M Al-Sarraf;M Le Blanc;P Giri;K Fu;J Cooper;T Vuong;A Forastiere;G Adams;W Sakr;D Schuller;F Ensley Proc of the American Society of Clinical Oncology 20:227a(#905)

Locally advanced nasopharyngeal cancer

JF Ensley;E Youseff;H Kim;G Yoo Current Treatment Options in Oncology 2(1):15-23

Behavioral science research in the cooperative group setting: the Southwest Oncology Group Experience

CC Gotay;CM Moinpour;S Moody-Thomas;ER Gritz;KS Albain;E DeAntoni;L Hansen;PA Ganz Journal of the National Cancer Institute 92(17):1381-1387

Improved five years survival with chemo-radiotherapy (CT-RT) vs radiotherapy (RT) in patients (PTS) with advanced nasopharyngeal cancer (NPC). Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) phase III study: progress report.

M Al-Sarraf;M LeBlanc;PGS Giri;K Fu;J Cooper;T Vuong;A Forastiere;G Adams;W Sakr;D Schuller;J Ensley Annals of Oncology 11(Suppl.4):90(#403)

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099

M Al-Sarraf;M LeBlanc;PGS Giri;KK Fu;J Cooper;T Vuong;AA Forastiere;G Adams;WA Sakr;DE Schuller;JF Ensley Classic Papers & Current Comments 4(3):649-656

Using the bootstrap for estimation in group sequential designs: an application to a clinical trial for nasopharyngeal cancer

M LeBlanc;J Crowley Statistics in Medicine 18:2635-2644

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099.

M Al-Sarraf;M LeBlanc;PGS Giri;KK Fu;J Cooper;T Vuong;AA Forastiere;G Adams;WA Sakr;DE Schuller;JF Ensley Journal of Clinical Oncology 16(4):1310-1317

Chemo-radiotherapy (CT-RT) vs radiotherapy (RT) in patients (pts) with advanced nasopharyngeal cancer (NPC). Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) phase III study: Progress report.

M Al-Sarraf;M LeBlanc;PGS Giri;K Fu;J Cooper;T Vuong;A Forastiere;G Adams;W Sakr;D Schuller;J Ensley Proc of the American Society of Clinical Oncology 17:385a(#1483)

Superiority of chemo-radiotherapy (CT-RT) vs radiotherapy (RT) in patients (pts) with locally advanced nasopharyngeal cancer (NPC). Preliminary results of intergroup (0099) (SWOG8892, RTOG8817, ECOG2388) randomized study.

M Al-Sarraf;M LeBlanc;PGS Giri;K Fu;J Cooper;T Vuong;A Forastiere;G Adams;W Sakr;D Schuller;J Ensley American Society of Clinical Oncology 15:313(#882)

Improved overall survival with chemo-radiotherapy (CT-RT) vs radiotherapy (RT) in patients (pts) with locally advanced nasopharyngeal cancer (NPC). Preliminary results of intergroup (0099) (SWOG8892, RTOG8817, ECOG2388) randomized study.

M Al-Sarraf;M LeBlanc;PGS Giri;K Fu;J Cooper;T Vuong;A Forastiere;G Adams;W Sakr;D Schuller;J Ensley 4th International Conference on Head and Neck Cancer Abstract-Book:118(#240)